Jane Street
ERNA icon

Jane Street’s Eterna Therapeutics ERNA Stock Holding History

Jane Street’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12
Closed -$846K – 10248
2021
Q3 		$846K Buy
12
+6
+100% +$518K ﹤0.01% 6249
2021
Q2 		$873K Buy
+6
New +$864K ﹤0.01% 6114

Other funds holding ERNA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's ERNA Position: Q1 2026 in Review

Jane Street opened a new position in Eterna Therapeutics (ERNA) in Q1 2026: 1,647 shares worth $8.19K. The stake represents ﹤0.01% of the portfolio and ranks #11320 among its holdings. This is a return to the name: Jane Street previously reported a position in ERNA as recently as Q2 2022.

Jane Street first reported a position in ERNA in Q2 2020 and has held it in 6 quarters since. The position peaked at $148K in Q3 2021. 15 funds tracked by Wall St. Rank hold ERNA as of Q1 2026.

  • Jane Street held 1,647 shares of Eterna Therapeutics worth $8.19K as of Q1 2026.
  • Eterna Therapeutics was a new Jane Street position in Q1 2026.
  • Eterna Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11320 holding.
  • Jane Street first reported a position in Eterna Therapeutics in Q2 2020 and has held it in 6 quarters since.
  • Jane Street's Eterna Therapeutics position peaked at $148K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.